Product overview
Type
Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3
Commercial Name
Bivalent type 1&3 Oral Poliomyelitis vaccine, IP (bOPV1&3)
Manufacturer
Haffkine Bio Pharmaceutical Corporation Ltd
Responsible NRA
Central Drugs Standard Control Organization
Country
India
URL
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
20
Diluent
Not Applicable
Route of Administration
Oral
Shelf Life
24 months
Storage Temperature
-20°C
Vaccine Vial Monitor
Type 2
Secondary Packaging
Carton of 50 vials (1000 doses)[Dimensions: 22.6 x 11.5x 3.6 cm]
Tertiary Packaging
Box of 24 cartons of 50 vials (1200 vials/ 24000 doses)[Dimensions: 58 x 46.5 x 37.5 cm]
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
none
Cold Chain Volume
0.94 cm3/dose (in secondary packaging)
Attachments
